These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3830248)

  • 1. The chronopharmacokinetics of indomethacin suppositories in healthy volunteers.
    Taggart AJ; McElnay JC; Kerr B; Passmore P
    Eur J Clin Pharmacol; 1987; 31(5):617-9. PubMed ID: 3830248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
    Jensen KM; Grenabo L
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacokinetic study of a prolonged release form of indomethacin.
    Guissou P; Cuisinaud G; Llorca G; Lejeune E; Sassard J
    Eur J Clin Pharmacol; 1983; 24(5):667-70. PubMed ID: 6873148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetic comparison of two indometacin containing suppositories with different vehicula.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A
    Arzneimittelforschung; 1984; 34(4):523-5. PubMed ID: 6547611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers.
    Lanza FL; Umbenhauer ER; Nelson RS; Rack MF; Daurio CP; White LA
    J Rheumatol; 1982; 9(3):415-9. PubMed ID: 6750118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
    Kuroda T; Yokoyama T; Umeda T; Matsuzawa A; Kuroda K; Asada S
    Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3319-25. PubMed ID: 6667541
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects.
    Clench J; Reinberg A; Dziewanowska Z; Ghata J; Smolensky M
    Eur J Clin Pharmacol; 1981; 20(5):359-69. PubMed ID: 7286046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
    Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
    J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
    Hippius M; Reinicke C
    Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronopharmacokinetics of indomethacin in rats.
    Guissou P; Cuisinaud G; Legheand J; Sassard J
    Arzneimittelforschung; 1987 Sep; 37(9):1034-7. PubMed ID: 3435597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
    Watanabe Y; Tone Y; Suzuki M; Matsumoto M
    Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of indomethacin suppository in primary dysmenorrhoea.
    al-Waili NS; Khalaf ZD
    Indian J Med Res; 1990 Aug; 92():298-301. PubMed ID: 2228077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers.
    Kunka RL; Hussey EK; Shaw S; Warner P; Aubert B; Richard I; Fowler PA; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):532-40. PubMed ID: 9209775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of oral and rectal indomethacin].
    Fredj G; Farinotti R; Hakkou F; Astier A; Dauphin A
    J Pharm Belg; 1983; 38(2):105-8. PubMed ID: 6875793
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of indomethacin on renal function in man.
    Baber N; Halliday L; Littler T; Orme M; Sibeon RG; Chan K
    Scand J Rheumatol; 1980; 9(1):52-4. PubMed ID: 7375871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing.
    Baber N; Sibeon R; Laws E; Halliday L; Orme M; Littler T
    Br J Clin Pharmacol; 1980 Oct; 10(4):387-92. PubMed ID: 7004474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nightly administration of ketoprofen (Orudis) and indomethacin suppositories in the management of osteoarthritis: a double-blind trial.
    Fava G; Galli L; Pollini C; Liverta C; Vicari A; Pontiroli AE
    J Int Med Res; 1977; 5(5):301-7. PubMed ID: 334604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of indomethacin and indomethacin metabolites administered continuously to patients with healthy or damaged kidneys].
    Stein G; Kunze M; Zaumseil J; Traeger A
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):470-3. PubMed ID: 924701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.